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Therapies with increasing specificity against pathogens follow the immune
system’s evolutionary course in maximizing host defence while minimizing
self-harm. Nevertheless, even completely non-specific stressors, such as reactive
molecular species, heat, nutrient and oxygen deprivation, and acidity can be
used to preferentially harm pathogens. Strategic use of non-specific stressors
requires exploiting differences in stress vulnerability between pathogens and
hosts. Two basic vulnerabilities of pathogens are: (i) the inherent vulnerability
to stress of growth and replication (more immediately crucial for pathogens
than for host cells) and (ii) the degree of pathogen localization, permitting the
host’s use of locally and regionally intense stress. Each of the various types of
non-specific stressors is present during severe infections at all levels of localiz-
ation: (i) ultra-locally within phagolysosomes, (ii) locally at the infected site,
(iii) regionally around the infected site and (iv) systemically as part of the acute-
phase response. We propose that hosts strategically use a coordinated system of
non-specific stressors at local, regional and systemic levels to preferentially
harm the pathogens within. With the rising concern over emergence of resistance
to specific therapies, we suggest more scrutiny of strategies using less specific
therapies in pathogen control. Hosts’ active use of multiple non-specific stressors
is likely an evolutionarily basic defence whose retention underlies and sup-
plements the well-recognized immune defences that directly target pathogens.
1. Introduction
The gold standard of host defences against pathogens is the use of highly targeted
effectors that avoid collateral damage to the host. By using molecular differences
between pathogens and host cells, the only cost of using specific effectors in defence
is their cost of manufacture. Examples include neutralizing antibodies, lysozyme
(which targets bacterial cell wall synthesis) and antimicrobial peptides. By contrast,
non-specific stressors such as heat, nutrient and oxygen restriction, reactive oxygen
and nitrogen species, and acidity can harm pathogens and host cells alike. Never-
theless, many host defences against pathogens involve non-specific stressors that
do indeed cause substantial collateral damage. The acute-phase response (APR),
which is the systemic response to infection [1,2], has a number of components
that are stressful. It has been proposed that hosts use the stressful components of
the APR, such as fever and nutrient restriction, to support the more intense stres-
sors at infected sites and to preferentially harm rapidly replicating pathogens [3].
This led us to initially explore the utility and costs of non-specific stress for host
defence against pathogens by using an agent-based model of a simple host infected
with local generic pathogens [4]. In this review, we further explore and extend the
implications of the host’s use of non-specific stressors as effectors, and suggest that
it is both more prevalent and important than is typically recognized.
We take a broad view of ‘pathogens’ to not only include microorganisms but
also infected host cells and tumour cells. We define stress as a disruption of
& 2016 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original
author and source are credited.
 on September 29, 2016http://rspb.royalsocietypublishing.org/Downloaded from 
homeostasis, and define stressors as agents causing harm or
simply incurring costs, which can be resisted by protective
stress responses acting to minimize harm. The costs of stress
can include the direct harm by the stressor (e.g. heat damage:
loss of function and cost of repair) and the costs to produce
the stressor (e.g. energy to produce febrile temperature). How-
ever, there are costs of activating protective stress responses
(e.g. protein synthesis in the heat shock response) as well as
the lost opportunities during protective responses (e.g. disrup-
tion of normal protein synthesis and delayed growth and
reproduction). Indeed, the most basic protective strategy against
the direct harm of stress is to delay growth and replication and to
undergo temporary quiescence. In general, organisms facing
potential stress are forced to weigh the relative costs of experien-
cing the stress itself (which may never occur) versus the costs of
maintaining reserves and of responding to the expected stress. In
addition, hosts must weigh the costs of using stress in defence
versus the risks of succumbing to infection due to inadequate
defence. An alternative to resisting the pathogens is for the
host to have tolerance to manageable numbers of the pathogens,
trading the high costs of eliminating every pathogen for the
lower continuous costs of pathogen and host harm and risks
of pathogen escape from control [5].
Studying non-specific stress for host defence against patho-
gens may seem like an intellectual backwater in this age of
discoveries of the complexity of evolved immune defences
and of spectacular biotechnological advances. The use of anti-
biotics ushered in the age of specific therapy, capitalizing upon
molecular differences between bacteria and host cells. Such
anti-infective therapy led the way for abandoning primitive
non-specific therapies such as inducing malaria to treat
syphilis [6] and Coley’s toxin, bacterial products that induced
immune responses to treat cancers [7]. Unfortunately, their
mode of action was never fully elucidated.
The APR likely played a key role in the efficacy of those
non-specific therapies. Fever, a well-known component of
the APR, has frequently been considered to have provided
this non-specific efficacy, but surprisingly there is not even
a consensus on how fever acts to protect [3,8,9]. Nor is
there consensus on how local heat therapy should be applied
to control superficial infections. Which is more important:
to stimulate immune responses or to directly harm the
pathogens? For instance, should the therapeutic goal be to
cause vasodilation using prolonged mild warmth, seeking
to stimulate blood flow thereby increasing inflow of nutrients
and increasing the functionality of inflammatory cells? Or
should the goal be to harm the pathogens, using brief periods
of more intense and damaging heat, seeking to avoid the
pathogens’ protective heat shock responses? In this review,
we advocate and provide the rationale for the latter approach
of using non-specific stressors as effectors to preferentially
harm the pathogens within.
2. Strategies for using non-specific stress
There are two fundamental strategies for effectively using
non-specific stress for defence: (i) capitalizing on differences
in vulnerability and (ii) localizing the stress. Owing to the
minor differences between tumour cells and normal cells, it
is no coincidence that we find striking similarity between
the prominent role of non-specific stress in anti-cancer
therapy as developed by clinical researchers [10] and the
now obscure, but basic, role of non-specific stress in innate
immunity as developed through natural selection.
(a) Capitalizing on differences in vulnerability
A universal principle is that growth and replication are more
vulnerable to stress than is quiescence. Growth and replication
require a gathering and splitting of resources, and the process
of synthesis typically involves intermediate stages that are
more fragile and vulnerable to stress than either the more
stable initial or final stages. A vivid example is that a house
may well withstand a hurricane, but actually building a house
during a hurricane would be folly. Resources (energy and/or
materials) that are devoted to growth and replication are not
available for withstanding stress. In other words, these
resources could have been used for construction of stress-
resistant defences, for repair, or for simply surviving until the
stress had passed. As expected, cells are most vulnerable to
heat and oxidative stress during replication [11–13]; and mito-
sis, protein synthesis (particularly folding), and ribosome
formation are particularly vulnerable to stress [14,15]. Since
pathogens typically rely on growth and replication for their
pathogenicity, their vulnerability to stress would be expected
to be greater than that of the host’s cells and of the host itself.
We tested the feasibility of using completely non-specific sys-
temic stress to control simulated localized infections of a simple
host in our agent-based model [4]. In the model, aside from
the pathogens having the ability to actively harm and gain
energy from host cells they were in contact with, the only differ-
ence from host cells was that the pathogens replicated faster. We
found that applying a uniform stress (energy deprivation) to our
simulated host, and to the pathogens within, was an effective but
costly and risky means of helping eliminate the pathogens.
Essentially, the model confirmed the universal trade-off of
using resources either for growth or for resisting stress.
Since the host initiates the defensive stress, it has the
advantage of controlling the intensity and timing to inflict
damage on the pathogens. Our agent-based modelling
showed the value of applying stress periodically. The relief
from stress allows the host to partially recover before starting
another round of stress. Although this relief from stress also
allows the pathogens to grow and replicate again, the patho-
gens are essentially lured into their most vulnerable state, to
be preferentially harmed again once the stress starts anew.
An anti-cancer analogue of intermittent stress is systemic
chemotherapy given every few weeks to allow the patient to
partially recover. We suggest that, if timed well, intermittent
stress can also enhance the vulnerability of the target cells.
(b) Localizing the stress
Localizing the non-specific stress allows for relatively higher
intensity at the infected site, thereby causing more harm to patho-
gens with less harm to distant host cells. As shown in table 1, we
describe four categories of spatial localization of stress: (i) ultra-
local, representing that occurring within phagolysosomes,
where the lack of collateral damage essentially meets our
definition of specific stress; (ii) local, representing the pathogen–
inflammatory cell interface at the infected site; (iii) regional, the
area around the infected site where there is often impaired
blood flow due to coagulation (thrombosis), microvascular
sludging, extravascular fibrin deposition, oedema and neutro-
phil extracellular traps (NETs) [22,23] and (iv) systemic, the
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Table 1 highlights that the same types of non-specific
stress, whether primarily destructive or growth inhibiting,
tend to occur at each level of localization. Rather than being
mere by-products, we propose that each stressor at each level
has immune utility. Besides the stress being more intense
with greater spatial localization, temporally the non-specific
stress begins more locally (i.e. first in the phagolysosomes),
such that the more costly systemic stress occurs only if the
pathogen cannot be controlled by more localized effectors.
The notion of localizing stress at various levels for defence
also has analogues with anti-cancer therapy. Examples at
each level are: (i) toxic agents bound to antibodies or lipo-
somes (ultra-local level); (ii) targeted radiation or heat,
creams with metabolite inhibitors, surgical excision (local
level); (iii) less targeted radiation, regional chemotherapy,
angiogenesis inhibitors and wide surgical excision (regional
level) and (iv) standard systemic chemotherapy affecting
growing and/or replicating cells (systemic level).
3. Examples of non-specific stressors for host
defence
While table 1 summarizes the primary non-specific stressors
used in host defence, it is instructive to describe some of these
examples in more depth. We briefly discuss iron restriction,
which is well recognized as a stress-based host defence, and
heat, which is surprisingly poorly understood in host defence.
(a) Iron
Iron is a key, and often limiting, nutrient for multiple func-
tions in almost all life forms; and the struggle for iron
between microorganisms and hosts is well known [24,25].
Growing and replicating cells have the special problem of
satisfying increasing resource needs, and iron restriction
can be viewed as a growth-inhibiting stressor. Bacteria and
fungi have evolved numerous mechanisms for extracting
iron from hosts, most notably the production of siderophores
which bind iron for their use. To offset this, neutrophils and
macrophages extract iron from phagolysosomes by natural
resistance-associated macrophage protein-1 (Nramp1) [26].
Additionally, at the locally infected site, neutrophil-derived
lactoferrin binds iron; and regionally, decreased blood flow
to the infected site further diminishes iron influx. Finally, at
the systemic level, plasma iron concentrations are reduced
as part of the APR due to decreased intestinal uptake and
sequestration by mononuclear phagocytes. The nutritional
deprivation of iron as a non-specific stressor is mirrored by
similar mechanisms at the same levels of localization for
zinc and manganese, which are also essential micronutrients
[26,27], though intriguingly, toxic amounts of zinc may be
delivered to phagolysosomes to kill bacteria [28].
(b) Heat
Analogous to the iron example, fever is a systemic stressor
used for host defence, despite the costs [3]. In this viewpoint,
fever acts strategically as a stressor in two ways: (i) energy to
generate the heat is diverted away from other uses, including
away from pathogens and (ii) the heat directly inflicts stress
[29,30] as a destructive or damaging stressor by enhancing
other sources of heat. However, because febrile temperatures
(i.e. core body temperatures) of 39.5–408C have limited
lethality for cultured cells [13,31] or for selected bacterial
pathogens in culture [8], and because numerous immune
functions are enhanced at slightly elevated temperatures, an
opposing view is that the main benefit of fever is not as a
stressor to harm pathogens but as an immune stimulant [8].
Unfortunately, heat as a local stressor has only rarely been
considered [32], and the warmth of inflammation is typically
attributed to vasodilation, with the local temperature thereby
limited to core body temperature. Nevertheless, local heat is
produced by the respiratory burst [33,34], which involves
the exothermic reaction of highly reactive oxygen, chlorine
and nitrogen intermediates, typically within phagolyso-
somes. Interestingly, macrophages in arterial plaques have
high expression of uncoupling protein 2 (UCP2), which can
generate heat at the expense of ATP production [35]. Further-
more, there is direct evidence that inflamed tissues are hotter
than core temperatures and that heat is, in fact, locally
generated, as demonstrated by the measurement of higher
temperatures (up to 28C) in inflamed atherosclerotic plaques
compared with adjacent artery walls [36,37].
Thus, testing of heat sensitivity of pathogens in culture or
through artificial whole-body hyperthermia is misleading
because: (i) the temperatures to which pathogens are exposed
at the infected site are currently unknown and (ii) in culture
the pathogens are spared the numerous other inflammatory
stressors applied locally, regionally and systemically. Indeed,
synergy has been described for heat and iron restriction
in vitro in killing the pathogenic bacterium, Pasteurella multocida,
when neither stressor alone was effective [38]. Similarly,
synergy of heat and low pH on reducing cell viability has
been shown [39]. In addition, although many immune
responses are indeed enhanced by slightly elevated tempera-
tures [9,40], rather than being the primary function of fever,
this characteristic is instead concordant with the view that
immune function evolved to adapt for stressful working con-
ditions, as proposed for improved immune efficacy in slight
acidity [41] and slight hypoxia [42]. Therefore, we view the pri-
mary evolved purpose of fever, rather than enhancing immune
function by expending large amounts of energy, is to act as a
systemic stressor, supporting and enhancing the effects of
other stressors at all levels of localization in host defence.
4. Expectations and implications of using non-
specific stress in defence
Once it is recognized that there are differences in vulner-
ability between pathogens and host cells (and the host as a
whole), it is reasonable to propose, as we do here, that
hosts evolved to actively enhance stress during infections to
preferentially harm the pathogens. From this perspective,
we suggest a number of expectations and implications were
this to be the case, which are outlined in table 2 and discussed
below. We exclude ultra-local stress occurring within phago-
lysosomes since stress at the ultra-local level has always
clearly been a defence and since it does not involve self-harm.
(a) Expectations of using local stress for host defence
(i) Immune cells should have special access to resources they
need
(a) Immune cells should bring along their own nutrients to the
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migrate to glucose-limited areas, one might expect that they
would bring their supplies with them. Indeed, while these
cells contain little glycogen while in the bloodstream, they
actively store glucose as glycogen when they migrate to
inflammatory sites [43,44].
(b) Immune cells should increase their local uptake of nutrients
at infected sites or when stimulated by inflammatory mediators and
pathogen products, in part to deprive nutrients to pathogens.
This increased uptake or utilization by stimulated leucocytes
has been shown for glucose [45,46], glutamine [47] and argi-
nine [48]. Borregaard & Herlin [49] found that neutrophils
use extracellular glucose in preference to their stored glyco-
gen, further supporting the perspective that they are acting
to deprive nearby pathogens of glucose.
(ii) Immune cells should actively make the infected site stressful
(a) Immune cells should actively deplete the nutrients, to the
point of being wasteful by taking in or destroying more
nutrients than they can use.
The high and energetically inefficient use of glucose via
glycolysis by neutrophils and classically activated (M1) macro-
phages, even in the presence of substantial oxygen (aerobic
glycolysis), has long been noted but not understood [49–51].
Rapidly replicating cells primarily use aerobic glycolysis (the
Warburg effect), presumably to divert carbon for biomaterial
synthesis [52] or particularly to reduce mitochondrial-derived
reactive oxygen species during the vulnerable period of DNA
synthesis [11]. However, neither rapid replication nor massive
size enlargement is important for immune cells arriving at
infected sites. Therefore, the large and apparently inefficient
usage of glucose by immune cells at infected sites certainly
seems wasteful yet is exactly what is needed to reduce its
availability to pathogens.
Glutamine is another key nutrient for host cells and
pathogens alike [53,54]. In parallel with the incomplete oxi-
dation of glucose by immune cells, it has been enigmatic as
to why neutrophils and macrophages take up far more gluta-
mine than they seem to need, simply storing most of it as
lower energy amino acids, notably glutamate, aspartate and
alanine [55,56]. Again, we suggest that what appears to be
wasteful is indeed deliberately wasteful.
Intriguingly, neutrophil secondary granules have been
found to contain glutaminase [57], which converts glutamine
to glutamate and ammonia, potentially depleting phagolyso-
somes of glutamine. Along these lines, arginase I, found in
neutrophil primary granules, has been proposed to enhance
fungal killing by depleting the phagolysosomes of arginine
as a nutrient [58]. Analogous to this is the active local
depletion of free iron by binding to locally secreted lactoferrin
and of zinc and manganese binding by neutrophil-secreted
calprotectin, which are considered host defences based on
local nutrient depletion [25,27]. As noted previously, phago-
cytes can actively remove iron, zinc and manganese directly
from their phagolysosomes.
(b) Immune cells should enhance the formation of harmful
waste products at infected sites. The large usage of glucose
through glycolysis has the advantage of causing stress not
only by reducing pathogens’ access to it, but also by produ-
cing correspondingly large amounts of lactic acid, making
the infected site even more stressful.
(iii) Host cells should avoid replicating and developing
at infected sites
Host cells should avoid replicating and developing at infected
sites, even though local replication would remove the need
for their migration to the site. This avoids the difficulty and
risk of replicating under stressful conditions. This contrasts
with the difficulty faced by pathogens trying to replicate at
the infected site. It is noteworthy that immune effector cells
typically replicate and develop at distant sites, such as in
the bone marrow, lymph nodes and spleen, places typically
not subject to local or regional stress. In accord with this
expectation is the recognition that most macrophages at
infected sites are bone marrow-derived monocytes [59] and
that M1 macrophages, which are aggressively antimicrobial,
typically do not replicate locally [60]. By contrast, M2 macro-
phages, which are involved in the low stress functions of
tissue repair and immune suppression, often do replicate
locally [60]. A tenet of wound healing is that proper healing
first requires resolution of infection/inflammation—infected
wounds are stressful, and having proliferating host cells
among proliferating pathogens removes the host’s advantage
of applying stress to help clear the infection.
(b) Expectations of using regional stress for host
defence
(i) Infection should be linked with impaired blood flow
to increase regional stress
Despite the vasodilation associated with inflammation, the
vascular supply to infected areas often becomes impaired.
The reduced flow occurs because of the linkage of coagu-
lation with inflammation leading to thrombosis, vascular
sludging from adherent leucocytes, fibrin deposition,
oedema and intra- and extravascular clogging by NETs.
This impaired blood flow around infected sites has been con-
sidered to have evolved to reduce the spread of pathogens
[22,23,61]. While the impaired blood supply has frequently
been noted as contributing to the harsh environment of
infected sites, this has been considered an unavoidable by-
product of the inflammatory response or pathogen
Table 2. Expectations and implications of using non-specific stress in
defence.
(a) local (i) immune cells should have access to needed
resources by
(a) bringing along resources and
(b) increasing resource uptake locally;
(ii) immune cells should make local site stressful by
(a) actively depleting resources and
(b) generating harmful waste products;
(iii) host cell replication should avoid stressful
environments;
(b) regional (i) increase stress by reducing blood flow: link
inflammation with coagulation;
(c) systemic (i) support regional and local stress with less
intensity but wider application;
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containment. By contrast, we have proposed that, along with
restricting pathogen spread, the impaired vascular flow to
infected sites also functions to further stress the pathogens
therein [4]. We suggest that this impaired vascularity not
only impedes the influx of nutrients, oxygen and antioxi-
dants, but also reduces the efflux of lactic acid and locally
produced heat, thereby preferentially harming the pathogens.
This proposal is supported both by our agent-based model
study [4] and common-sense analogies in anti-cancer
therapy.
The roles of stress as a defence and pathogen containment
are linked in that restricting pathogen spread permits the host
to apply more intense stress to the pathogens than would
otherwise be feasible. Conversely, uncontained pathogens
escape the stress (locally intense and regionally less intense),
allowing faster and safer replication.
(c) Expectations of using systemic stress in host defence
(i) Systemic stress of the acute-phase response should be similar
to but less intense than local and regional stressors
This similarity would enhance or support more localized
stressors while not overburdening distant host cells. By
‘enhance’ we propose, for example, that it is more efficient
to keep essential iron from phagocytized pathogens if there
is already local depletion of iron at the infected site, which
in turn has restricted blood flow (and iron availability)
regionally, with the systemic blood also having reduced con-
centrations of iron. Likewise, the anaemia of inflammation
[62], leading to mild hypoxia, may enhance more extreme
hypoxia at the infected site.
(ii) Systemic stress as a defence should be extremely costly since
it affects otherwise untouched host cells distant from the
infection site
Because of the importance of this point, we devote the next
section to the costs and benefits of systemic stress as a defence.
5. Costs and benefits of using systemic stress
for host defence
A goal of the field of ecological immunology is to quantitate
the costs of resisting infection, since these costs reduce the
resources an organism can devote to reproduction, mainten-
ance and surviving environmental challenges. One
approach has been to measure the energetic costs associated
with activating the various components of the immune
response following immunologic challenges (reviewed in
[63]). However, others have suggested that these costs related
to actually mounting a typical immune response are rela-
tively low in comparison to the major costs associated with
mounting a fever, undergoing food restriction or sustaining
the collateral self-harm and associated life-history trade-offs
[1,64–67]. While local and regional stress can be lethal in
critical organ systems (e.g. heart, lungs, brain and kidneys),
self-induced systemic stress can be lethal regardless of
where the infection is localized. Indeed, sepsis entails the
excessive use of systemic defence [68,69]. The costs from the
stressful components of the APR come from having to
harm all host cells while trying to preferentially harm more
localized pathogens. As such, these expensive defences
should not be intensively invoked if less costly defences can
effectively control the infection [64]. The stressors of the
APR should be thought of as the defence of last resort, in
which case the costs essentially become irrelevant to a host
that would otherwise be killed from pathogen overgrowth.
Our perspective allows us to see the high cost of systemic
stress in a positive light and to resolve a key paradox. Why
should severe infection be associated with systemic nutrient
deprivation, anorexia, delayed gastric emptying, and inhib-
ited absorption of sugars [70] and glutamine [20] just at the
time when resources should be needed to fight the infection?
Much of the basis of our argument is that the greater
sensitivity of pathogens to non-specific stress means that
stressing the pathogens as a defence often trumps immediate
nourishment of ‘typical’ immune defences. The effective use
of the strategy of self-stressing requires adequate resources
before the infection, as noted by Owen-Ashley & Wingfield
[71], who found that birds in poor condition mount a less
intense APR (assessed by sickness behaviours such as
inactivity and anorexia). The term ‘immune brinksmanship’
was chosen to describe the gamble that the infected host
has enough resources at the start of the infection to ‘out-
stress’ the pathogens [3]. As suggested by Straub et al. [72],
the resources should be taken by reprioritization and catabo-
lism of distant tissues for immune defence. Indeed, resources
should be directed towards making antibodies, leucocytes,
complement components and other acute-phase reactants.
However, there are physical limits to the amounts of each
of these blood-borne defences that can be used. How can
the host put additional remaining resources to use in fighting
a severe infection? We propose that the host’s production and
withstanding of systemic stress to control localized pathogens
is an effective means of using the resources of distant host
cells. The resources of distant host cells need not be directly
transported to immune tissues but can be used by the distant
cells themselves to survive the systemic stress to which the
entire host subjects itself and the pathogens within. In this
view, an infected host with severe clinical cachexia/wasting
is likely expending its resources in an appropriately strategic
defence. While dying from infection can be considered a
tragedy, dying from infection while still having plenty of
unused or inaccessible resources would be particularly tragic.
6. Conclusion
In the evolutionary arms races between pathogens and hosts,
pathogens have evolved a number of ways to avoid and inhi-
bit host defences [19]. However, the multitude of cellular
targets of each of several fundamental stressors (e.g. nutrient
restriction, heat, reactive molecular species) makes these
non-specific stressors a formidable defence, though costly if
untargeted. Now that resistance to specific therapies seems
to be evolving more rapidly than newer specific therapies
can be discovered and developed, the use of non-specific
stress should be re-examined. Fruitful areas of inquiry
involve exploring interactions among multiple types of stres-
sors, notably destructive stressors and growth-inhibitory
stressors, to determine the extent to which they may be syner-
gistic, additive or antagonistic. Finding ideal regimens of
timing and intensity are crucial, since stress can either
cause significant damage to pathogens when applied rapidly
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applied slowly and predictably. In sum, the development of
new therapies should consider strategies that exploit the
differences in pathogen and host vulnerability to non-specific
therapeutics in order to preferentially harm the pathogens.
In the long course of host–pathogen interactions, there
has been selection for ever more sophisticated defences
against ever more virulent pathogens, leading to the develop-
ment of the amazingly complex acquired immune system,
having memory and high specificity. However, even many
of the effectors of the more fundamental innate immune
system have specificity (e.g. lysozyme and antimicrobial pep-
tides) against pathogens, which has allowed hosts to use ever
more pathogen-damaging defences while avoiding collateral
damage. Our intention has been to examine how the use of
the most primitive effectors of innate immunity, completely
non-specific stressors, play a role in defence. In contrast to
the obvious means through which specific stressors can pro-
vide defence, in many cases it has not even been apparent
how, or even that, the self-harm during infections could pro-
vide some degree of host defence. For example, the mode of
action of numerous non-specific systemic stressors of the APR
has been unclear; and the stressful conditions at and around
infection sites are typically regarded as harmful to the host,
being unavoidable by-products of the host–pathogen
struggle, without consideration that the pathogens may be
disproportionately harmed. In retrospect, the efficacy of
non-specific stressors, actively applied by the host locally,
regionally and systemically, makes sense. After all, the
same principles are used in therapy against tumour cells,
pathogenic cells differing from normal host cells primarily
in growth rate and their degree of localization. Indeed, the
strategy of using non-specific stress to capitalize on differ-
ences in vulnerability between contestants has universal
application. We propose that to the extent that hosts can
harm themselves to preferentially harm the pathogens
within, we should expect hosts to actively use this strategy
as a defence.
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